StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC)
Equities research analysts at StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Cantor Fitzgerald initiated coverage on shares of GlycoMimetics in a research report on Friday, March 21st. They issued an “overweight” rating […]
Equities research analysts at StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Cantor Fitzgerald initiated coverage on shares of GlycoMimetics in a research report on Friday, March 21st. They issued an “overweight” rating […]
-logo-1200x675.png?v=20211206081858&w=240&h=240&zc=2){kind=logo}
